Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent ...

While there were outliers, Marston said a major chunk of the investments are concentrated in a few key hubs: Pennsylvania and ...

Danish dermatology specialist Leo Pharma and its CEO Christophe Bourdon came to San Francisco to attend the J.P. Morgan ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved ...

The news comes on the heels of President Trump calling for Congress to enact his most recent attempt to lower healthcare costs in America, The Great Healthcare Plan. The proposal is a series of ...

From the corporate jets of Teterboro Airport to the crowded halls of the J.P. Morgan Healthcare Conference, it’s a good time ...

AbbVie struck a big deal to enter the hot PD-1xVEGF bispecific space. | In this week's Asia news recap, AbbVie struck a big ...

According to reporting from Bloomberg at the J.P. Morgan Healthcare Conference that ended today in San Francisco, ...

Johnson & Johnson (JNJ) stock slips after the company's Q4 2025 earnings which beat on the topline but stood in line with the ...

Tanabe Pharma America’s oral melanocortin-1 receptor (MC1R) agonist has met the primary endpoint in a Phase III trial in patients with erythropoietic protoporphyria (EPP) and X-linked protoporphyria ...

Scientists have collaborated to develop a new class of highly precise filtration membranes. The research, published in the ...